- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05513677
Characterisation of Biofilm Growth on Coated vs. Uncoated Urinary Catheter Surfaces in Normal Clinical Use (PRO30CSP)
Evaluated Patients: 5 patients (Convenience sample: non-blinded, non-randomised)
Selection follows documented hospital protocols for routine catheterisation
Measured Patients: 30 patients (Convenience sample: non-blinded and non-randomised)
- 20 who receive the M4D coated catheter.
- 10 who receive the standard uncoated catheters used in routine patient care.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Evaluated Patients: 5 patients (Convenience sample: non-blinded, non-randomised)
Selection follows documented hospital protocols for routine catheterisation
Measured Patients: 30 patients (Convenience sample: non-blinded and non-randomised)
- 20 who receive the M4D coated catheter.
- 10 who receive the standard uncoated catheters used in routine patient care.
1) Evaluation (5 patients, coated catheter)
A convenience sample of patients will be selected to receive the Camstent coated catheter for their routine care. These enrolments are drawn from among those recommended for routine catheterisation, for up to 28 days and in accordance to existing hospital protocols. There is no change to the routine protocols for insertion, maintenance, withdrawal, or documentation of the patient's catheterisation. Following use, the catheter is discarded according to the hospital's procedures.
Staff questionnaires will be completed to capture general use information. These will document the opinions of the nurse inserting and withdrawing the catheter, and may include questions for the patient, to record their experience. There will be no collection of patient information, and no analysis of the discarded catheter.
2) Measurement (10 patients receiving uncoated catheters, 20 patients receiving coated catheters)
The data collection will include 10 patients who have received the standard hospital issued uncoated catheter and 20 patients who have received the Camstent coated catheter. There will be no randomisation and no blinding.
The first 10 patients needing routine urinary catheterisation to drain their bladder for up to 28 days whilst in hospital will receive the routine hospital issued catheter and will looked after by hospital and staff as standard practice.
The next 20 patients needing routine urinary catheterisation to drain their bladder whilst in hospital will receive a coated catheter. There will be no change to the intended use of the catheter for patients where it is deemed medically necessary to drain urine from the urinary bladder via the urethra using the catheter device for up to 28 days. There will be no change to any patient care or catheterisation procedures.
All 30 catheters will be sent to a laboratory for surface examination rather than immediately disposed of as medical waste. Harvested catheters will be bagged in an airtight plastic bag and tagged with a record identifier. A record identifier will be used to establish catheter traceability and duration, and will not compromise patient anonymity. The catheter will be kept refrigerated and transported to the analysis laboratory at Nottingham University within two days.
At the Nottingham Laboratory, the catheters will be subjected to qualitative and quantitative analysis to determine the percentage of biofilm coverage on the surface. This will initially be achieved using staining followed by microscopic visual examination of the catheter surface, and images taken of any surface encrustation.
For Fluorescence Microscopy, the procedure will be:
- Cut the catheter into segments then wash three times in ~15 ml of PBS with gentle agitation.
- Transfer the washed catheter segments into the wells of a sterile 24 well plate and stain with SYTO17 Red Fluorescent Nucleic Acid Stain.
- Segments will be imaged using a laser scanning confocal microscope using a 10 X objective lens over a 1024 μm x 1024 μm area.
- A z-section will be imaged (each section is 4μm apart with 36 images taken over 140μm) such that the entire curved surface is imaged. The coverage data will then be taken from a maximum intensity z-projection.
- Data analysis will be carried out in ImageJ using the maximum intensity z-projection images.
- Images will be converted to 8-bit greyscale images, a threshold applied to select the data correctly and the biofilm coverage measured.
- The percentage of coverage for each sample will be computed as (Light) / (Light + Dark) * 100%.
Aggregate descriptive statistics will be calculated, and biofilm coverage will be plotted against the duration of catheterisation as a scattergram. The study is not powered to permit statistical analysis.
Prior laboratory experiments predict that the difference in biofilm coverage could exceed 80%. If larger differences are seen in harvested catheters, then a Total Cell Count assay, in which the biofilm is sonicated free of the surface and then assessed through serial dilution, may be substituted for Fluorescence Microscopy.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Middlesbrough, Royaume-Uni, TS4 3BW
- The James Cook University Hospital,
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
-
Exclusion Criteria:
• Patients under age 18.
- Patients that have or recently (within 3 weeks) had a urinary catheter, or those with signs of current urinary tract infection.
- Patients who they have had previous radiation therapy in lower pelvis.
- Patients who are cognitively impaired, or are unwilling to give consent
- Patients with a potentially immunocompromised condition
- Patients that require further antibiotics after initial dose, or those that are administered antibiotics following an infection whilst the trial urinary catheter is in situ
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Non randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: Norme de soins
|
Standard of Care
|
Expérimental: M4D coated catheter
Experimental
|
Coated catheter
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
The primary outcome is the percentage of catheter surface colonised by biofilm, calculated as (light / (light + dark) x 100% in measurement of stained samples using fluorescence microscopy.
Délai: 30 days
|
The primary outcome is the percentage of catheter surface colonised by biofilm, calculated as (light / (light + dark) x 100% in measurement of stained samples using fluorescence microscopy.
|
30 days
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Secondary outcomes will be logging of events, including catheter blockage or presumed CAUTI.
Délai: 30days
|
Secondary outcomes will be logging of events, including catheter blockage or presumed CAUTI.
|
30days
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- PRO30CSP
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Infections des voies urinaires
-
West Virginia UniversityInscription sur invitationInfection de la peau et des tissus mous | Infection gastro-intestinale | Infection pulmonaire | Infection des os et des articulations | Infection endovasculaire | Infection génito-urinaireÉtats-Unis
-
Radboud University Medical CenterSint MaartenskliniekActif, ne recrute pasInfection du site opératoire | Infection articulaire | Infection, site chirurgical | Prothèse Infection Hanche et Genou | Infection liée aux prothèses | InfectionProPays-Bas
-
Croydon Health Services NHS TrustComplétéInfection du site opératoire | Infection de la plaie | Césarienne; Infection | Infection périnéaleRoyaume-Uni
-
Taipei Medical University WanFang HospitalInconnue
-
Ondine Biomedical Inc.ComplétéInfection du site opératoire | Infection nosocomiale | Infection associée aux soins de santéÉtats-Unis
-
Angela BiancoStryker NordicRésiliéCésarienne | Infection du site opératoire | Infection nosocomialeÉtats-Unis
-
Leiden University Medical CenterRadboud University Medical Center; University Medical Center Groningen; Erasmus... et autres collaborateursRecrutementInfection prothétique-articulaire | Infection de la hanche | Infection; Genou, ArticulationPays-Bas
-
Cairo UniversityRecrutementInfection postopératoire | Complications de la césarienne | Infection vaginaleEgypte
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemComplétéInfection du site opératoire | Infection superficielle du site opératoire | Infection profonde du site chirurgical | Infection du site chirurgical d'un organe/de l'espaceÉtats-Unis
-
Hospices Civils de LyonRecrutement
Essais cliniques sur Standard of Care
-
Evolution Optiks LimitedComplétéAstigmatisme | Acuité visuelle | AnisométropieÉtats-Unis
-
Compedica IncProfessional Education and Research InstituteRecrutementUlcère du pied diabétiqueÉtats-Unis, Canada
-
University of CalgaryHealth CanadaActif, ne recrute pas
-
ULURU Inc.Navy Advanced Medical Development (NAMD) CommandActif, ne recrute pasBlessures et BlessuresÉtats-Unis
-
RapidPulse, IncComplétéAVC ischémique aiguDanemark, Lettonie, Turquie, Brésil, Espagne
-
University Health Network, TorontoAnemia Institute for Research & EducationComplétéCardiopathie | CoagulopathieCanada
-
University Hospital Southampton NHS Foundation...University of Southampton; South Central Ambulance service; Hampshire and Isle...Pas encore de recrutementCrise cardiaque | Réanimation cardiopulmonaire | Arrêt cardiaque hors de l'hôpitalRoyaume-Uni
-
Medtronic Cardiac Rhythm and Heart FailureRésiliéInsuffisance cardiaque congestiveÉtats-Unis
-
University of Southern CaliforniaRecrutement
-
University of StellenboschComplété